Incontinence Devices are used in the treatment of urinary tract and nephrological disorder of patient such as Chronic Kidney Disease (CKD), Kidney Stone, Benign Prostatic Hyperplasia (BPH), End Stage Renal Disease (ESRD) and urinary incontinence of pelvic organ prolapse.
According to WHO, more than 190 million patients are suffering from chronic renal failure and undergo renal dialysis and more than 220 million males suffer from diseases associated with prostate glands such as swelling that results in blockage of the flow of urine through the body. The United States national institute of diabetes and digestive and kidney diseases reported that more than 2 million kidney stone patients are diagnosed every year across the U.S.
Nephrology and Urology Incontinence Devices Market: Drivers and Restraints
Presently, the global market for incontinence devices is primarily driven by the rising prevalence of Chronic Kidney Disease (CKD), Benign Prostatic Hyperplasia (BPH) and End Stage Renal Disease (ESRD) Also, increasing prevalence of diabetes and hypertension, aging population and a shortage of kidney donors for transplant. Growing awareness programmes bout these particular disease and personal hygiene among patients will lead the market in the forecast years.
Browse Full Report@ http://www.futuremarketinsights.com/reports/nephrology-and-urology-incontinence-devices-market
Also, with the increase in healthcare expenditure and favorable reimbursement in the developed countries the market is expected to have a healthy growth.
Nephrology and Urology Incontinence Devices Market: Segmentation
Nephrology and urology-incontinence devices global market is segmented into following types:
Protective Garments for Incontinence